363 related articles for article (PubMed ID: 23711061)
1. What is the role of antimicrobial peptides (AMP) in acne vulgaris?
Harder J; Tsuruta D; Murakami M; Kurokawa I
Exp Dermatol; 2013 Jun; 22(6):386-91. PubMed ID: 23711061
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
Lim HS; Chun SM; Soung MG; Kim J; Kim SJ
Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris.
Marta Guarna M; Coulson R; Rubinchik E
FEMS Microbiol Lett; 2006 Apr; 257(1):1-6. PubMed ID: 16553825
[TBL] [Abstract][Full Text] [Related]
4. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
Popovic S; Urbán E; Lukic M; Conlon JM
Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of acne vulgaris: recent advances.
Bhambri S; Del Rosso JQ; Bhambri A
J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
[TBL] [Abstract][Full Text] [Related]
6. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity.
Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B
Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673
[TBL] [Abstract][Full Text] [Related]
7. Acne sans P. acnes.
Shaheen B; Gonzalez M
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):1-10. PubMed ID: 22458782
[TBL] [Abstract][Full Text] [Related]
8. Propionibacterium acnes: an update on its role in the pathogenesis of acne.
Beylot C; Auffret N; Poli F; Claudel JP; Leccia MT; Del Giudice P; Dreno B
J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):271-8. PubMed ID: 23905540
[TBL] [Abstract][Full Text] [Related]
9. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.
Kim J
Dermatology; 2005; 211(3):193-8. PubMed ID: 16205063
[TBL] [Abstract][Full Text] [Related]
10. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
Han R; Blencke HM; Cheng H; Li C
Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
[TBL] [Abstract][Full Text] [Related]
11. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for acne vulgaris: current status and future directions.
Simonart T
Am J Clin Dermatol; 2013 Dec; 14(6):429-35. PubMed ID: 24019180
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice.
Ryu S; Han HM; Song PI; Armstrong CA; Park Y
PLoS One; 2015; 10(7):e0132619. PubMed ID: 26197393
[TBL] [Abstract][Full Text] [Related]
14. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies.
Dessinioti C; Katsambas AD
Clin Dermatol; 2010; 28(1):2-7. PubMed ID: 20082942
[TBL] [Abstract][Full Text] [Related]
15. Isotretinoin therapy changes the expression of antimicrobial peptides in acne vulgaris.
Borovaya A; Dombrowski Y; Zwicker S; Olisova O; Ruzicka T; Wolf R; Schauber J; Sárdy M
Arch Dermatol Res; 2014 Oct; 306(8):689-700. PubMed ID: 24916439
[TBL] [Abstract][Full Text] [Related]
16. Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris.
Liu PF; Hsieh YD; Lin YC; Two A; Shu CW; Huang CM
Curr Drug Metab; 2015; 16(4):245-54. PubMed ID: 26264195
[TBL] [Abstract][Full Text] [Related]
17. [Cytotoxicity in acne vulgaris].
Vignale RA; Espasandín J; Lasalvia E; Borras A
Med Cutan Ibero Lat Am; 1982; 10(1):31-6. PubMed ID: 6214674
[TBL] [Abstract][Full Text] [Related]
18. Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions.
Kwon HH; Yoon JY; Park SY; Suh DH
Br J Dermatol; 2013 Nov; 169(5):1152-5. PubMed ID: 23795647
[TBL] [Abstract][Full Text] [Related]
19. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
Załuga E
Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
[TBL] [Abstract][Full Text] [Related]
20. Acne: a new model of immune-mediated chronic inflammatory skin disease.
Antiga E; Verdelli A; Bonciani D; Bonciolini V; Caproni M; Fabbri P
G Ital Dermatol Venereol; 2015 Apr; 150(2):247-54. PubMed ID: 25876146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
